NCT05433870View on ClinicalTrials.gov

Inflammatory Biomarkers for the Diagnosis of oPRES

CompletedOBSERVATIONAL
Enrollment

621

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Posterior Reversible Encephalopathy SyndromeInflammatory BiomarkersNeutrophil-lymphocyte Ratio
Interventions
OTHER

Whether the PE or E patient combined with PRES

According to the Diagnostic criteria of PRES, all the patients grouped into two groups.

Trial Locations (1)

510150

Department of Obstetrics and Gynecology, Key Laboratory for Major Obstetric Diseases of Guangdong Province, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Dunjin Chen

OTHER